Rapid Nutrition (ALRPD) Investor presentation summary

Strategic vision and market opportunity

• Focus on building a global health tech platform for personalized nutrition and immune science, leveraging AI and clinically validated wellness systems.

• Targeting the $6.8 trillion global wellness market with a recurring revenue model and €5M in secured funding.

• Emphasis on preventive healthcare, high-value demographics, and data-driven personalization to drive customer retention.

Business model and platform evolution

• Transitioning from a premium nutraceutical portfolio to a precision wellness and immune science platform with AI-driven personalization.

• Multi-engine revenue model includes product sales, personalized subscriptions, practitioner channels, and licensing partnerships.

• Platform monetization pathways are opening, supported by capital structure reset and AI integration.

Product portfolio and scientific credibility

• Operates a growing portfolio of evidence-based wellness brands, including patented antiviral and immunity-boosting formulations.

• Participation in large-scale US clinical studies and international trials, reinforcing science-backed credibility.

• Granted patents, proprietary formulations, and regulatory-compliant development standards.